Archive · 5 Jun 2025
Caplin Point Acquires Triwin Pharma in Mexican Market
Caplin Point, a company, is buying Triwin Pharma in Mexico.
Caplin Point will use Triwin Pharma to sell its products in Mexico, including marketing and distribution.
This is like Caplin Point is setting up a local store in Mexico.
The deal was made on June 3rd, 2025 and is expected to be done within a month, when the payment goes through.
This helps the company to get into the Mexican government's deals and have a local stock to sell their products.
The goal is to boost sales using a similar strategy that has worked in other areas of Latin America.
Caplin Point's subsidiary executed a share purchase agreement to acquire Triwin Pharma.
The acquisition will make Triwin Pharma a wholly-owned subsidiary.
Triwin Pharma will be the front-end entity for product sales in Mexico.
The acquisition aligns with Caplin Point's strategy in Latin American markets.
The deal is expected to complete within 30 days after payment.
- Who
- Caplin Point Laboratories Ltd., through its subsidiary Caplin Point Far East Ltd., acquired Triwin Pharma.
- What
- Caplin Point Laboratories Ltd. acquired Triwin Pharma.
- When
- June 3, 2025: Share purchase agreement executed.
- Where
- Mexico
- Why
- Strategic decision to gain a local partner in Mexico for market entry.
- Agreement Date
- June 3, 2025
- Target Company Location
- Mexico
- Acquiring Entity
- Caplin Point Far East Ltd.
- Acquired Company
- Triwin Pharma
- Triwin Pharma Turnover (March 31, 2025)
- Nil
- Completion Timeframe
- 30 days
- Triwin Pharma Incorporation Date
- February 12, 2019